NZ's AFT Pharmaceuticals gains on launch of non-opioid pain management solution in US

AFT Pharmaceuticals

04/06/2024 02:10

** Shares of AFT Pharmaceuticals  AFT.NZ  rise as much as
0.65% to NZ$3.12, their highest level since May 24
    ** Pharmaceutical co announces agreement with Alexso to
distribute Combogesic (Maxigesic Rapid Tablets), a non-opioid
pain management solution, in the United States
    ** Says co expects launch of second patented pharmaceutical
in the U.S. market to occur this financial year
    ** Stock down 11.43% this year, as of last close

 (Reporting by Sherin Sunny in Bengaluru)
 ((Sherin.Sunny@thomsonreuters.com))